SELLAS Life Sciences (SLS) Research & Development (2010 - 2026)

SELLAS Life Sciences (SLS) has 17 years of Research & Development data on file, last reported at $5.1 million in Q1 2026.

• On a quarterly basis, Research & Development rose 60.03% year-over-year to $5.1 million in Q1 2026; TTM through Mar 2026 was $17.9 million, a 4.4% increase from a year earlier, with the FY2025 full-year figure at $16.0 million, down 16.1% from the prior year.
• Research & Development for Q1 2026 stood at $5.1 million, up from $4.7 million in the prior quarter.
• Over the last five years, Research & Development for SLS reached as high as $7.2 million in Q1 2023 and fell as low as $3.2 million in Q1 2025.
• Historically, Research & Development has averaged $5.0 million across 5 years, with a median of $5.1 million in 2023.
• Across the five-year window, Research & Development soared 72.3% in 2022 and plunged 37.29% in 2025, its largest moves.
• Year by year, Research & Development stood at $5.8 million in 2022, then fell by 12.81% to $5.1 million in 2023, then decreased by 12.95% to $4.4 million in 2024, then advanced by 6.6% to $4.7 million in 2025, then climbed by 8.44% to $5.1 million in 2026.
• Per Business Quant data, the three most recent Research & Development figures were $5.1 million in Q1 2026, $4.7 million in Q4 2025, and $4.2 million in Q3 2025.